Cytoreductive Nephrectomy Following ICI-Based Dual Combination Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Surgical Safety of Deferred Cytoreductive Nephrectomy Following Pretreatment with Immune Checkpoint Inhibitor-based Dual Combination Therapy
Eur Urol Oncol 2021 Dec 18;[EPub Ahead of Print], NM Graafland, B Szabados, C Tanabalan, T Kuusk, F Mumtaz, R Barod, D Nicol, E Boleti, T Powles, JB Haanen, A BexFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.